Loading…
Back To Schedule
Wednesday, June 22 • 11:00am - 12:00pm
#320: De-Risking Decentralized: Understanding the Dimensions of Risk and Maximizing Data Quality in Decentralized Trials

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-22-610-L04-P ; CME 1.00; RN 1.00

How should your organization be monitoring risk in decentralized trials? This session will share insights of how to ensure effective oversight of dimensions of risk in decentralized trials and quality of participant self-generated data.

Learning Objectives

Discuss the evolving landscape of decentralized research; Appraise new sources of risk in decentralized trials and approaches to mitigate risks; Demonstrate how centralized monitoring technologies provide effective oversight of key risks and ensure quality for participant self-generated data; Propose opportunities to maximise patient engagement through analysis of participant usage metrics.

Chair

John James Hall, PhD

Speaker

Industry Update
Lynne Cesario

Industry Update
Patrick Nadolny, MS

Industry Update
Richard Young


Speakers
avatar for John Hall

John Hall

Senior Vice President, Europe and AsiaPac, CluePoints, Belgium
John is a senior life sciences executive with over 20 years of experience in the life sciences industry. He is currently SVP at CluePoints, a leader in the field of RBQM, where he leads commercial activities across Europe and Asia Pacific and CluePoints decentralised trial strategy... Read More →
MA

Mayank Anand

Vice President and Head, Global Data Strategy and Management, GlaxoSmithKline
PN

Patrick Nadolny

Global Head, Clinical Data Management, Sanofi, France
Global Head, Clinical Data Management, Sanofi Chair of the SCDM Innovation Committee SCDM Board Member Mr. Nadolny has almost 30 years of industry experience across pharmaceutical, device and biologics as well as technology solution development. Mr. Nadolny is a pragmatic leader focusing... Read More →
LC

Lynne Cesario

Senior Director, Global Risk Based Monitoring Lead, Pfizer Inc, United States
avatar for Richard Young

Richard Young

Vice President, Vault CDMS Strategy, Veeva Systems, United Kingdom
As a veteran of almost 25-years in life sciences, Richard has held multiple operational roles in Pharma and CRO organisations, such as GlaxoWellcome, Novo Nordisk, Chiltern and Parexel, before moving into eClinical Solutions, with Cmed and Medidata. Today, Richard brings Veeva customers... Read More →

Wednesday June 22, 2022 11:00am - 12:00pm CDT
Room 176 McCormick Place 2301 South Indiana Avenue Gate 40 Chicago, IL 60616
  03: Data-Tech in Clinical Trials, Forum |   08: RD Quality-Compliance, Forum